Q4 2026 Earnings Call July 15, 2026 10:00 AM EDTCompany ParticipantsJared Mattingley - VP, Treasurer, Investor Relations ...
A new Data for Progress survey found that Medicare for All, regulating AI, and taxing the rich were the top issues that would ...
Equity Insider News Commentary, The United States has decided it wants two things it spent decades letting atrophy: a domestic uranium supply chain, and a new generation of reactors small enough to ...
Interesting Engineering on MSN
Giant 150-foot wind-powered wing begins propulsion trials on 754-foot-long vessel
Wind-powered commercial shipping expanded its operational footprint on July 1, 2026, when the vehicle ...
Every morning, millions of Americans engage in a quiet, collective ritual. We wake up, often pull a smartphone from our ...
A cardiologist explains why the RingConn Gen 3 smart ring represents the future of wearable health with accurate tracking, sleep insights, and wellness monitoring.
Q2 2026 Earnings Call July 16, 2026 4:30 AM EDTCompany ParticipantsAdam WarbyTim Steiner - CEO & Executive DirectorNick la ...
Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.
In cities across the country, underground calisthenics battles are pushing elite athletes to their limits ...
Raina Penchansky and Ali Berman on helping human creators in the age of AI ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results